MDL | MFCD09842349 |
---|---|
Molecular Weight | 516.45 |
Molecular Formula | C25H24O12 |
SMILES | OC1=CC(O)=C(C(C(O[C@@H]2O[C@@H](C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]2O)=C(C3=CC=C(O)C=C3)O4)=O)C4=C1 |
SL 0101-1 (SL0101), a kaempferol glycoside, isolated from the tropical plant F. refracta , is a cell-permeable, selective, reversible, ATP-competitive p90 Ribosomal S6 Kinase (RSK) inhibitor, with an IC 50 of 89 nM [1] . SL 0101-1 (SL0101) is a selective RSK1/2 inhibitor, with a K i of 1 μM [2] .
RSK1 |
SL 0101-1 (SL0101) shows proliferation inhibition in human breast cancer cell line MCF-7 and produces a cell cycle block in G 1 phase [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |